See also this year's filing and all EDGAR filings for this company.
PDF Report 0001281895_2023_ROCKET_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001281895, ROCKET PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 364,060,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 64,878,000 |
| 2 | PropertyPlantAndEquipmentNet | 29,009,000 |
| 3 | remainder_Assets | 93,860,000 |
| 4 | LiabilitiesCurrent | 39,169,000 |
| 5 | LiabilitiesNoncurrent | 3,683,000 |
| 6 | remainder_Liabilities | 19,269,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 58,773,000 |
| 9 | ResearchAndDevelopmentExpense | 165,570,000 |
| 10 | remainder_Expenses | 1,862,000 |
| 11 | remainder_Revenues | 3,889,000 |
| 12 | remainder_NetIncome | 453,000 |
| 13 | remainder_ComprehensiveNetIncome | -196,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 551,807,000 |
| 1 | Liabilities | 62,121,000 |
| 2 | Expenses | 226,205,000 |
| 3 | Revenues | 3,889,000 |
| 4 | StockholdersEquity | 489,686,000 |
| 5 | NetIncome | -221,863,000 |
| 6 | ComprehensiveNetIncome | -221,961,000 |
| 7 | BaseVar | 422,335,500 |
| 8 | EconomicCapitalRatio | 2.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time
